vertex pharmaceuticals - Search News

Vertex Pharmaceuticals Shares Gain

The Wall Street Journal on MSN · 7h

Vertex Pharmaceuticals Shares Gain After FDA Approves Non-Opioid Pain Drug

Shares of Vertex Pharmaceuticals rose after Journavx, the company’s oral non-opioid pain medication, received Food and Drug Administration approval.

Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVX™ (suzetrigine), an oral, non-opioid, highly selective NaV1.8 pain signal inhibitor for the treatment of adults with moderate-to-severe acute pain.

The Associated Press on MSN · 1h

FDA approves new painkiller that shows promise and challenges of opioid alternatives

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.

American Association of Individual Investors1d

Which Is a Better Investment, Natera, Inc. or Vertex Pharmaceuticals Incorporated Stock?

Learn more about whether Natera, Inc. or Vertex Pharmaceuticals Incorporated is a better investment based on AAII's A+ ...

Vertex, U.K. reach reimbursement deal for CRISPR-based medicine for sickle cell disease

People in England with sickle cell will be able to get the world’s first CRISPR-based medicine under an agreement between the ...

11hon MSN

Jim Cramer on Vertex Pharmaceuticals Incorporated (VRTX)’s Suzetrigine: ‘I Don’t See A Lot Of Upside Because That Was The Drug Of The Future For Vertex’

We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we are going to take a look at ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results